Home  |  About Us  |  Site Directory  |  Clinical Services  |  Grand Rounds  |  RIP  |  Research  |  Education

 

 
Home > Resident Case Studies > Week 11 Case 1 > Case 1 Discussion

RESIDENT CASE STUDIES

Week 11 June 28 - July 4, 2003: Case 1   

Table of Contents | List of Diagnoses | Case 1 | Case 2 | Case 3

32 year old male with right knee mass that is negative for actin, desmin, and Myo D1 with no SSX/SSY translocation

Discussion 
Epithelioid sarcoma (ES) is a distinct tumor of unknown lineage affecting mainly adolescents and young adults. It is rare in infants and the elderly. It may be misdiagnosed as a benign lesion especially benign granulomatous process.1 The most commonly affected areas are the flexor surface of fingers, hand, wrist and forearm. It may be superficial or deep-seated. The trunk, head and neck regions are seldom involved by classical epithelioid sarcoma.1 When superficial it usually presents as firm, slow growing, painless solitary or multiple nodules/plaque-like lesions. There may be ulceration of the skin. Deep-seated lesions are often attached to tendons, tendon or aponeurosis.1 The size may range from a few millimeters to several centimeters, (especially in deep seated tumors). 

Histologically, the classic ES shows a characteristic nodular growth pattern frequently (but not always) with central necrosis (geographic necrosis), simulating benign necrobiotic processes such as rheumatoid nodule and granuloma annulare. The typical nodule is composed of a mixed proliferation of eosinophilic epithelioid and spindle cells with nuclear atypia, vesicular nuclei and small nucleoli.1 The number of mitoses is usually low--often less than 5/hpf. The cells can have rhabdoid features.1 ES is characteristically immunoreactive for vimentin and epithelial markers (e.g. LMK, HMK, EMA, CK8 and CK19).1,2 Half of the cases are reported positive for CD34,2 and occasional reactivity for muscle specific actins, NSE and S100 have been reported.

ES is an aggressive sarcoma with high recurrence rate3 with an overall recurrence rate of 80% at 10 years.4 

Adverse prognostic factors in ES include male sex, advanced age at diagnosis, large tumor size (>5cm), deep location, nuclear pleomorphism, high mitotic activity, presence of vascular and or nerve invasion, multiple recurrence, presence of lymph node metastasis at diagnosis.1

References:

1Fletcher CDM, Unni KK, Mertens F. (Eds.): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press: Lyon 2002.

2Miettinen M, Fanburg-Smith JC, Virolainen M, et al. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol 1999;30:934-942.

3Halling AC, Wollan PC, Pritchard DJ, et al. Epithelioid sarcoma: a clinicopathologic review of 55 cases. Mayo Clin Proc 1996;71:636-642.

4Chase DR. Do “rhabdoid features“ impart a poorer prognosis to proximal-type epithelioid sarcoma? Adv Ana Pathol 1997;4:293-299.